Back

Focusing antibody responses to the fusion peptide in rhesusmacaques

Cottrell, C. A.; Pratap, P. P.; Cirelli, K. M.; Carnathan, D. G.; Enemuo, C. A.; Antansijevic, A.; Ozorowski, G.; Sewall, L. M.; Gao, H.; Greene, K. M.; Allen, J. D.; Ngo, J. T.; Choe, Y.; Nogal, B.; Silva, M.; Bhiman, J.; Pauthner, M. G.; Irvine, D. J.; Montefiori, D.; Crispin, M.; Burton, D. R.; Silvestri, G.; Crotty, S.; Ward, A. B.

2023-06-27 immunology
10.1101/2023.06.26.545779 bioRxiv
Show abstract

Immunodominance of antibodies targeting non-neutralizing epitopes and the high level of somatic hypermutation within germinal centers (GCs) required for most HIV broadly neutralizing antibodies (bnAbs) are major impediments to the development of an effective HIV vaccine. Rational protein vaccine design and non-conventional immunization strategies are potential avenues to overcome these hurdles. Here, we report using implantable osmotic pumps to continuously deliver a series of epitope-targeted immunogens to rhesus macaques over the course of six months to elicit immune responses against the conserved fusion peptide. Antibody specificities and GC responses were tracked longitudinally using electron microscopy polyclonal epitope mapping (EMPEM) and lymph node fine-needle aspirates, respectively. Application of cryoEMPEM delineated key residues for on-target and off-target responses that can drive the next round of structure-based vaccine design.

Matching journals

The top 3 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.